Qingdao Central Hospital

No.127, Siliu (S) Rd., Sifang Dist., Qingdao, Shandong, China

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

62.5%

Phase 3

12.5%

Phase 4

8.3%

Not Applicable

4.2%

Trial Status Distribution

Active, not recruiting

4.2%

Completed

29.2%

Not yet recruiting

4.2%

Recruiting

50.0%

Unknown

12.5%

Clinical Trials

Trials sponsored by this organization (24)

Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer

Phase 2

Active, not recruiting

interventional

Jul 202549 participants

Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions

Phase 2

Recruiting

interventional

Jul 202560 participants

Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification

Phase 2

Recruiting

interventional

Jan 202560 participants

Nutrition Impact on Immunotherapy of Cancer

Phase 3

Recruiting

interventional

Jun 2024300 participants

Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer

Recruiting

observational

Apr 202470 participants

Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer

Phase 2

Recruiting

interventional

Sep 202390 participants

Effects of Dapagliflozin on Inflammatory Factorslevel and Prognosis in Type 2 Diabetes With Acute Myocardial Infarction

Phase 4

Completed

interventional

May 2023143 participants

Colchicine Use for Primary Prevention of Coronary Artery Disease

Phase 3

Not yet recruiting

interventional

Dec 20226,792 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations